P
TMO icon

&Partners’s Thermo Fisher Scientific TMO Stock Holding History

&Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Buy
26,876
+2,130
+9% +$1.16M 0.07% 272
2025
Q4 		$14.3M Buy
24,746
+3,301
+15% +$1.87M 0.08% 244
2025
Q3 		$10.4M Buy
21,445
+970
+5% +$451K 0.07% 255
2025
Q2 		$8.33M Buy
20,475
+8,497
+71% +$3.55M 0.06% 264
2025
Q1 		$5.96M Buy
11,978
+10
+0.1% +$5.42K 0.06% 262
2024
Q4 		$6.36M Buy
11,968
+3,323
+38% +$1.83M 0.08% 240
2024
Q3 		$5.35M Buy
8,645
+5,260
+155% +$3.11M 0.1% 194
2024
Q2 		$1.87M Buy
3,385
+2,170
+179% +$1.24M 0.08% 219
2024
Q1 		$706K Sell
1,215
-262
-18% -$147K 0.1% 210
2023
Q4 		$784K Buy
1,477
+642
+77% +$311K 0.19% 120
2023
Q3 		$423K Buy
835
+70
+9% +$37.3K 0.2% 96
2023
Q2 		$399K Hold
765
– – 0.18% 101
2023
Q1 		$441K Buy
765
+27
+4% +$15.2K 0.21% 93
2022
Q4 		$406K Sell
738
-91
-11% -$48.2K 0.2% 96
2022
Q3 		$420K Sell
829
-13
-2% -$7.28K 0.24% 93
2022
Q2 		$457K Hold
842
– – 0.26% 89
2022
Q1 		$497K Buy
842
+29
+4% +$16.7K 0.28% 88
2021
Q4 		$542K Hold
813
– – 0.33% 74
2021
Q3 		$464K Hold
813
– – 0.3% 81
2021
Q2 		$410K Buy
813
+13
+2% +$6.13K 0.27% 91
2021
Q1 		$365K Buy
800
+130
+19% +$62K 0.27% 91
2020
Q4 		$312K Sell
670
-30
-4% -$14.1K 0.26% 91
2020
Q3 		$309K Sell
700
-100
-13% -$41.3K 0.31% 75
2020
Q2 		$290K Buy
800
+84
+12% +$28.2K 0.35% 76
2020
Q1 		$203K Sell
716
-100
-12% -$31.5K 0.32% 99
2019
Q4 		$265K Sell
816
-100
-11% -$30.3K 0.32% 109
2019
Q3 		$267K Sell
916
-90
-9% -$25.8K 0.35% 104
2019
Q2 		$295K Sell
1,006
-140
-12% -$38.6K 0.41% 82
2019
Q1 		$314K Buy
+1,146
New +$285K 0.45% 78

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

&Partners's TMO Position: Q1 2026 in Review

&Partners increased its Thermo Fisher Scientific (TMO) stake by 8.6% in Q1 2026, buying an estimated $1.16M and bringing the position to 26,876 shares worth $13.2M. The position accounts for 0.07% of the portfolio, ranked #272.

&Partners first reported a position in TMO in Q1 2019 and has held it in 29 quarters since. The position peaked at $14.3M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • &Partners held 26,876 shares of Thermo Fisher Scientific worth $13.2M as of Q1 2026.
  • &Partners bought 2,130 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.16M.
  • Thermo Fisher Scientific made up 0.07% of &Partners's portfolio in Q1 2026, its #272 holding.
  • &Partners first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 29 quarters since.
  • &Partners's Thermo Fisher Scientific position peaked at $14.3M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.